Azra AI vs Patients.app
Both read records to trigger action rather than to inform a reader, and they pick different high consequence moments. Azra watches pathology and radiology reports arrive and turns findings into assigned work for a navigator, which addresses patients lost between diagnosis and follow up. Patients.app screens records for surgical readiness, pulling in outside records so the assessment is made on the whole picture rather than on what happens to be in the local chart, with human structures downstream of the output. Both are useful and both share a blind spot: they publish what they surface and not what proportion of it was worth surfacing. Ask each for the actionable rate, because a system that generates fifty cases a week for a navigator who can work fifteen has not solved the problem, it has moved it.
- Both products are instrument level rather than generic, screening records for surgical readiness and for a second high consequence workflow rather than summarising charts in general.
- Every result links back to its source, and genuine human structures sit downstream of both products rather than the output going straight into a decision.
- It retrieves records from outside the organisation as part of the workflow, which is where the missing information for a surgical readiness decision usually lives.
- It converts findings in pathology and radiology reports into assigned work, which is an operational output rather than an informational one.
- The integration is live and deep, consuming interface feeds as reports land rather than running a periodic query.
- Coverage started in oncology across the whole service line and has broadened, so the workflow is proven on the hardest version of the problem.
Side by Side
| Axis | A Azra AI |
P Patients.app |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Summarization & Chart Review page.
Both products act on the assumption that acting sooner is better, and neither publishes the counterpart figure: what proportion of surfaced cases are actionable, and how much work is generated by cases that were not. Azra publishes no health privacy statement, business associate terms or security attestation despite consuming live clinical feeds.
Patients.app publishes no retention position or training use statement, and its efficiency claim of time saved per case is unaccompanied by any measure of what was missed. Neither publishes pricing or a subgroup performance analysis.